Stents Bioresorbable

This channel includes news and new technology innovations for bioresorbable stents (BRS). These devices are also referred to as bioabsorbable stents, bioresorbable scaffolds and dissolving stents. BRS are designed as an alternative to permanent metallic stent implants, which cause issues in a small number of patients with in-stent restenosis, late-stent thrombosis and require use of long-term antiplatelet therapy. Metallic stents also cause issues with CT and MRI imaging and may prevent future options for coronary bypass graft (CABG) surgery. BRS are supposed to remove avoid these issues by dissolving and disappearing from the vessel after a period of 2-4 years. This, returns the vessel to its natural state and allows for the return of vasodilatation and vasoconstriction.

 

stents, bioresorbable, clinical trial, clinical study

Image courtesy of Reva

News | December 31, 2014

December 31, 2014 — Reva Medical initiated patient enrollment with its Fantom...

Boston Scientific, EVOLVE II, Synergy, bioresorbable stent
News | December 10, 2014

December 10, 2014 — In the first successful United States trial of a bioabsorbable polymer stent, the Boston...

Stentys, coronary stent, MiStent SES, Micell Technologies Inc.
News | November 14, 2014

Nov. 14, 2014 — Micell Technologies Inc. announced commercialization plans for its MiStent...

DAIC Editor Dave Fornell

DAIC Editor Dave Fornell

News | November 03, 2014

By Dave Fornell, editor of DAIC Magazine

...
Feature | October 08, 2014

October 8, 2014 — Abbott announced the start of the ABSORB IV clinical trial, which will test whether the Absorb...

News | October 07, 2014

October 7,2014 — Amaranth Medical announced patient enrollment in multiple centers in Colombia, South America in...

Blog | September 26, 2014

By Dave Fornell, editor of DAIC Magazine

The key take away messages from the 26th annual Transcatheter...

News | September 26, 2014
September 26, 2014 — A first-of-its kind study comparing the safety and efficacy of biodegradable polymer sirolimus-...
News | September 24, 2014

September 24, 2014 — A new study that compares the use of an everolimus-eluting...

ABSORB II Study DES Xience Abbot Vascular
Feature | September 24, 2014

September 24, 2014 — Abbott announced positive one-year clinical results from ABSORB II, the world's first...

Videos | Stents Bioresorbable | September 24, 2014

DAIC Editor, Dave Fornell, interviews  Jim Hermiller, M.D., FACC, director of interventional cardiology, St. Vincent...

bioresorbable stents, dissolving stents, Absorb stent, BVS

Abbott has spearheaded bioresorbable stent technology with the development with its BVS. By far the BVS has the most clinical experience, with more than 13,000 patients around the world having been treated with the device.

Feature | Stents Bioresorbable | September 03, 2014 | Dave Fornell
News | July 10, 2014

July 10, 2014 — 480 Biomedical announced it has been awarded Phase II funding from the National Heart, Lung, and...

Elixir Medical Corp. DESolve 100 CE mark
Feature | May 13, 2014

May 13, 2014 — Elixir Medical Corp. received European CE mark approval for its DESolve 100 Novolimus-eluting...

Feature | April 16, 2014

April 16, 2014 — Abbott announced it has completed enrollment of three...

Overlay Init